173 related articles for article (PubMed ID: 27071853)
21. Parvovirus B19 integration into human CD36+ erythroid progenitor cells.
Janovitz T; Wong S; Young NS; Oliveira T; Falck-Pedersen E
Virology; 2017 Nov; 511():40-48. PubMed ID: 28806616
[TBL] [Abstract][Full Text] [Related]
22. Synthesis of 3-(Imidazo[2,1-
Conti I; Morigi R; Locatelli A; Rambaldi M; Bua G; Gallinella G; Leoni A
Molecules; 2019 Mar; 24(6):. PubMed ID: 30875983
[TBL] [Abstract][Full Text] [Related]
23. RNA Binding Protein RBM38 Regulates Expression of the 11-Kilodalton Protein of Parvovirus B19, Which Facilitates Viral DNA Replication.
Ganaie SS; Chen AY; Huang C; Xu P; Kleiboeker S; Du A; Qiu J
J Virol; 2018 Apr; 92(8):. PubMed ID: 29437973
[TBL] [Abstract][Full Text] [Related]
24. The small 11 kDa nonstructural protein of human parvovirus B19 plays a key role in inducing apoptosis during B19 virus infection of primary erythroid progenitor cells.
Chen AY; Zhang EY; Guan W; Cheng F; Kleiboeker S; Yankee TM; Qiu J
Blood; 2010 Feb; 115(5):1070-80. PubMed ID: 19861680
[TBL] [Abstract][Full Text] [Related]
25. Human parvovirus B19 causes cell cycle arrest of human erythroid progenitors via deregulation of the E2F family of transcription factors.
Wan Z; Zhi N; Wong S; Keyvanfar K; Liu D; Raghavachari N; Munson PJ; Su S; Malide D; Kajigaya S; Young NS
J Clin Invest; 2010 Oct; 120(10):3530-44. PubMed ID: 20890043
[TBL] [Abstract][Full Text] [Related]
26. Antiviral activity of cidofovir against telomerase-specific replication-selective oncolytic adenovirus, OBP-301 (Telomelysin).
Ouchi M; Kawamura H; Urata Y; Fujiwara T
Invest New Drugs; 2009 Jun; 27(3):241-5. PubMed ID: 18754077
[TBL] [Abstract][Full Text] [Related]
27. The 11-Kilodalton Nonstructural Protein of Human Parvovirus B19 Facilitates Viral DNA Replication by Interacting with Grb2 through Its Proline-Rich Motifs.
Xu P; Chen AY; Ganaie SS; Cheng F; Shen W; Wang X; Kleiboeker S; Li Y; Qiu J
J Virol; 2019 Jan; 93(1):. PubMed ID: 30282717
[TBL] [Abstract][Full Text] [Related]
28. Telbivudine Reduces Parvovirus B19-Induced Apoptosis in Circulating Angiogenic Cells.
Zobel T; Bock CT; Kühl U; Rohde M; Lassner D; Schultheiss HP; Schmidt-Lucke C
Viruses; 2019 Mar; 11(3):. PubMed ID: 30845701
[No Abstract] [Full Text] [Related]
29. Comparative activities of lipid esters of cidofovir and cyclic cidofovir against replication of herpesviruses in vitro.
Williams-Aziz SL; Hartline CB; Harden EA; Daily SL; Prichard MN; Kushner NL; Beadle JR; Wan WB; Hostetler KY; Kern ER
Antimicrob Agents Chemother; 2005 Sep; 49(9):3724-33. PubMed ID: 16127046
[TBL] [Abstract][Full Text] [Related]
30. Impaired Endothelial Regeneration Through Human Parvovirus B19-Infected Circulating Angiogenic Cells in Patients With Cardiomyopathy.
Schmidt-Lucke C; Zobel T; Schrepfer S; Kuhl U; Wang D; Klingel K; Becher PM; Fechner H; Pozzuto T; Van Linthout S; Lassner D; Spillmann F; Escher F; Holinski S; Volk HD; Schultheiss HP; Tschope C
J Infect Dis; 2015 Oct; 212(7):1070-81. PubMed ID: 25805750
[TBL] [Abstract][Full Text] [Related]
31. Cidofovir inhibits genome encapsidation and affects morphogenesis during the replication of vaccinia virus.
Jesus DM; Costa LT; Gonçalves DL; Achete CA; Attias M; Moussatché N; Damaso CR
J Virol; 2009 Nov; 83(22):11477-90. PubMed ID: 19726515
[TBL] [Abstract][Full Text] [Related]
32. Effect of Leflunomide, Cidofovir and Ciprofloxacin on replication of BKPyV in a salivary gland in vitro culture system.
Jeffers-Francis LK; Burger-Calderon R; Webster-Cyriaque J
Antiviral Res; 2015 Jun; 118():46-55. PubMed ID: 25790744
[TBL] [Abstract][Full Text] [Related]
33. The formation and modification of chromatin-like structure of human parvovirus B19 regulate viral genome replication and RNA processing.
Xu H; Hao S; Zhang J; Chen Z; Wang H; Guan W
Virus Res; 2017 Mar; 232():134-138. PubMed ID: 28263841
[TBL] [Abstract][Full Text] [Related]
34. Successful replication of parvovirus B19 in the human megakaryocytic leukemia cell line MB-02.
Munshi NC; Zhou S; Woody MJ; Morgan DA; Srivastava A
J Virol; 1993 Jan; 67(1):562-6. PubMed ID: 8416383
[TBL] [Abstract][Full Text] [Related]
35. Enhanced inhibition of orthopoxvirus replication in vitro by alkoxyalkyl esters of cidofovir and cyclic cidofovir.
Kern ER; Hartline C; Harden E; Keith K; Rodriguez N; Beadle JR; Hostetler KY
Antimicrob Agents Chemother; 2002 Apr; 46(4):991-5. PubMed ID: 11897580
[TBL] [Abstract][Full Text] [Related]
36. Chloroquine and its derivatives exacerbate B19V-associated anemia by promoting viral replication.
Bönsch C; Kempf C; Mueller I; Manning L; Laman M; Davis TM; Ros C
PLoS Negl Trop Dis; 2010 Apr; 4(4):e669. PubMed ID: 20436917
[TBL] [Abstract][Full Text] [Related]
37. Human parvovirus B19 DNA replication induces a DNA damage response that is dispensable for cell cycle arrest at phase G2/M.
Lou S; Luo Y; Cheng F; Huang Q; Shen W; Kleiboeker S; Tisdale JF; Liu Z; Qiu J
J Virol; 2012 Oct; 86(19):10748-58. PubMed ID: 22837195
[TBL] [Abstract][Full Text] [Related]
38. Cidofovir inhibits polyomavirus BK replication in human renal tubular cells downstream of viral early gene expression.
Bernhoff E; Gutteberg TJ; Sandvik K; Hirsch HH; Rinaldo CH
Am J Transplant; 2008 Jul; 8(7):1413-22. PubMed ID: 18510636
[TBL] [Abstract][Full Text] [Related]
39. Identification of AXL as a co-receptor for human parvovirus B19 infection of human erythroid progenitors.
Ning K; Zou W; Xu P; Cheng F; Zhang EY; Zhang-Chen A; Kleiboeker S; Qiu J
Sci Adv; 2023 Jan; 9(2):eade0869. PubMed ID: 36630517
[TBL] [Abstract][Full Text] [Related]
40. Sequence changes in the human adenovirus type 5 DNA polymerase associated with resistance to the broad spectrum antiviral cidofovir.
Kinchington PR; Araullo-Cruz T; Vergnes JP; Yates K; Gordon YJ
Antiviral Res; 2002 Oct; 56(1):73-84. PubMed ID: 12323401
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
